Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - CHANGE IN WORKING CAPITAL
Change in Working Capital AVTX - Avalo Therapeutics, Inc.
-9.24 M
LAST VALUE
-106.27%
2 YEAR CAGR
-15.53%
5 YEAR CAGR
-31.40%
10 YEAR CAGR